TrialResults - center   -  Clinical trials results database in

GAMMA



Clinical trials of Aventis brand of valsartan (valsartan)     pdf

Clinical trials of Aventis brand of valsartan (valsartan) and meta-analysis are available for the following clinical conditions:


acute myocardial infarction

acute myocardial infarction, angiotensin-receptor blockers, all type of patients    pdf

Valsartan+ACE inhibitor vs ACE inhibitor only :  VALIANT (valsartan+capropril), 2003  - 
Valsartan vs Captopril :  VALIANT (valsartan alone), 2003  - 

atrial fibrillation

atrial fibrillation, prevention, patient with history of atrial fibrillation    pdf

valsartan vs placebo :  GISSI-AF (Disertori), 2009  - 

atrial fibrillation, prevention, patients without history of AF (primary prevention)    pdf

valsartan vs placebo :  Val-HeFT (AF ancillary study), 2003  - 

diabetes

diabetes, anti hypertensive agent, type1 and 2 diabetic patients with hypertension    pdf

valsartan vs amlodipine :  NAGOYA HEART, 2011  - 

diabetes, prevention, all type of patients    pdf

valsartan vs placebo :  NAVIGATOR valsartan, 2010  - 

diabetes, prevention, people with impaired glucose tolerance    pdf

valsartan vs placebo :  NAVIGATOR valsartan, 2010  - 

diabetes, angiotensin-receptor blockers, all type of patients    pdf

valsartan vs amlodipine :  NAGOYA HEART, 2011  - 

diabetes, angiotensin renin system blockade, all type of patients    pdf

valsartan vs amlodipine :  NAGOYA HEART, 2011  - 

heart failure

heart failure, angiotensin-receptor blockers, all type of patients    pdf

valsartan+ACE inhibitor vs ACE inhibitor only :  V-HeFT, 1999  -  Val-HeFT, 2001  -  VALIANT (valsartan+capropril), 2003  - 
valsartan vs captopril :  VALIANT (valsartan alone), 2003  - 
valsartan vs enalapril :  HEAVEN, 2002  - 
valsartan vs Lisinopril :  Mazayev et al. (vs lisinopril, 1998  - 
valsartan vs no valsartan :  VALIDD, 2007  - 
valsartan vs placebo :  Mazayev et al. (vs placebo), 1998  - 

heart failure, angiotensin-receptor blockers, patients previously untreated with ACE inhibitors    pdf

valsartan vs Lisinopril :  Mazayev et al. (vs lisinopril, 1998  - 
valsartan vs placebo :  Mazayev et al. (vs placebo), 1998  - 

heart failure, angiotensin-receptor blockers, patients already receiving ACE inhibitor    pdf

valsartan+ACE inhibitor vs ACE inhibitor only :  V-HeFT, 1999  -  Val-HeFT, 2001  - 
valsartan vs enalapril :  HEAVEN, 2002  - 

heart failure, angiotensin-receptor blockers, patients with preserved-LVEF heart failure    pdf

valsartan vs no valsartan :  VALIDD, 2007  - 

hypertension

hypertension, anti hypertensive agent, diabetic patients    pdf

valsartan vs amlodipine :  VALUE, 2004  -  NAGOYA HEART,  -  NAGOYA HEART, 2011  - 

hypertension, anti hypertensive agent, all type of patient    pdf

valsartan vs amlodipine :  VALUE, 2004  - 
valsartan vs control :  JIKEI, 2007  - 
valsartan vs non ARB strategy :  KYOTO HEART Study, 2009  - 

hypertension, angiotensin-receptor blockers, all diseases requiring ACEi (HF, CHD, HT,...)    pdf

valsartan vs amlodipine :  VALUE, 2004  -  NAGOYA HEART,  - 
Valsartan vs Captopril :  VALIANT/Val, 2003  - 
valsartan vs control :  JIKEI, 2007  - 
valsartan vs non ARB strategy :  KYOTO HEART Study, 2009  - 

impaired fasting glucose

impaired fasting glucose , prevention, all type of patients    pdf

valsartan vs placebo :  NAVIGATOR valsartan, 2010  - 

miscellaneous

miscellaneous, angiotensin-receptor blockers, all type of patients    pdf

valsartan vs amlodipine :  VALUE, 2004  - 
valsartan vs control :  JIKEI, 2007  - 
valsartan vs non ARB strategy :  KYOTO HEART Study, 2009  - 

patients at high risk for cardiovascular events

patients at high risk for cardiovascular events, angiotensin-receptor blockers, all type of patients    pdf

valsartan vs amlodipine :  VALUE, 2004  - 
valsartan vs non ARB strategy :  KYOTO HEART Study, 2009  - 



Entry terms: N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine, valsartan, N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine, Diovan, Tareg, Novartis brand of valsartan, Kalpress, Lacer brand of valsartan, Miten, CEPA brand of valsartan, Provas, Schwarz brand of valsartan, Sanol brand of valsartan, Vals, Esteve brand of valsartan, walsartan, CGP 48933, Nisis, Aventis brand of valsartan, amlodipine, valsartan drug combination, amlodipine - valsartan, amlodipine-valsartan, Exforge, Novartis brand of amlodipine, valsartan drug combination, N-(1-oxo-4-hydroxypentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-L-valine, valeryl 4-hydroxy valsartan



Search Aventis brand of valsartan clinical trials in Pubmed

Search Aventis brand of valsartan clinical trials in ClinicalTrials.gov

Search Aventis brand of valsartan clinical trials in Wikipedia

Search Aventis brand of valsartan in drugs.com




browse_trt3b

 
(c) 2006-2011TrialResults-center - All rights reserved Sitemap | Feedback | Disclaimer & Privacy Policy | Copyright | Home | Top
This website is certified by Health On the Net Foundation. Click to verify. This site complies to the HONcode standard for trustworthy health information: verify here.
Last uptaded on 2011/5
100 user(s) connected

Creative Commons License TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .


OpenSearch feed - Add TrialResults-center.org to your browser's search bar